NHS National Pharmaceuticals - Everolimus and terminated agreement products

Concepts

• pharmaceutical products
• nhs national pharmaceuticals
• everolimus
• runcorn
• period of framework agreement
• agreement products
• oral products
• hospital only products
• potential periods of call
• authority's discretion

Location

Description

Tender Close: 26th April, 13:00. Invitation to offer for NHS National Pharmaceuticals - Everolimus and terminated agreement products Offer reference number: CM/PHG/21/5632 Period of framework agreement: Start date to be confirmed with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. Potential periods of call-offs under the framework agreement: Everolimus: All regions: to commence as soon as possible with an end date of 01/03/2022 Oral Products: All regions: to commence as soon as possible with an end date of 28/02/2022 Hospital Only Products: DLS, DNE, DNW, DLN and DSW regions: to commence as soon as possible with an end date 31/01/2022

CPV Codes

• 33600000 - Pharmaceutical products

Indicators

• Contract is suitable for SMEs.

Other Information

Document No. 00 - Read Me First Document - Everolimus https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kLka/Q9R6UvHRLYx... Document No. 07a - Quality control technical sheet https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kLkz/df3zKmJ7mlf... Document No. 01 - Invitation to offer covering letter https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kLkf/aa.c0jLqkn7... Document No. 02 - Terms of offer https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kLkk/AqnLTNbSiXB... Document No. 05a (v) Product Listing & Usage - Hospital Only Products CM_PHG_21_5632_02 https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kLkh/N.ngD0FFcr2... Document No. 05b - Selectt offer schedule instructions https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kLku/NXDYgLz3iwb... Document No. 03 - Framework Agreement and Terms and Conditions https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kLkp/ah6w_KrHQyh... Document No. 04 - Contract technical specification https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kLkl/OpfXYhW0hFE... Document No. 05a (ii), 05a (iv), 05a (vi) CM_PHG_21_5632 SELECTT Application https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kLkg/khmtJiVSTjD... Document No. 05a (i) Product Listing & Usage - Everolimus CM_PHG_21_5632_00 https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kLkm/qbdByrJNHur... Document No. 05a (iii) Product Listing & Usage - Oral (plus non-parenteral) products CM_PHG_21_5632_01 https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kLkn/3Uqdn9uozzw... Document No. 08 - Confidential information schedule https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kLl4/oLiz.eGY8KA... FTS Notice - NHS National Pharmaceuticals - Everolimus and terminated agreement products https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kLl5/4C4KS_U1lHn... Document No. 06 - Form of offer https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kLkb/d.hnrkbP90k... Document No. 07b - Guidance for Performing a Pharmaceutical Quality Assessment of Licensed Medicines for the NHS https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/4J000000kLko/vFBvJs87O6C...